Neural response to catecholamine depletion in remitted bulimia nervosa

Standard

Neural response to catecholamine depletion in remitted bulimia nervosa : Relation to depression and relapse. / Ermakov, E.; Smirnova, L.; Ivanova, S. и др.

в: European Neuropsychopharmacology, Том 27, № 7, P.1.f.019, 01.07.2017, стр. 633-646.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Ermakov, E, Smirnova, L, Ivanova, S, Zaharova, O, Buneva, V & Nevinsky, G 2017, 'Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse', European Neuropsychopharmacology, Том. 27, № 7, P.1.f.019, стр. 633-646. https://doi.org/10.1016/j.euroneuro.2017.04.002

APA

Ermakov, E., Smirnova, L., Ivanova, S., Zaharova, O., Buneva, V., & Nevinsky, G. (2017). Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse. European Neuropsychopharmacology, 27(7), 633-646. [P.1.f.019]. https://doi.org/10.1016/j.euroneuro.2017.04.002

Vancouver

Ermakov E, Smirnova L, Ivanova S, Zaharova O, Buneva V, Nevinsky G. Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse. European Neuropsychopharmacology. 2017 июль 1;27(7):633-646. P.1.f.019. doi: 10.1016/j.euroneuro.2017.04.002

Author

Ermakov, E. ; Smirnova, L. ; Ivanova, S. и др. / Neural response to catecholamine depletion in remitted bulimia nervosa : Relation to depression and relapse. в: European Neuropsychopharmacology. 2017 ; Том 27, № 7. стр. 633-646.

BibTeX

@article{5bb34ba703744a56a7b315df4a1ffd10,

title = "Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse",

abstract = "Introduction: Schizophrenia is known to be a multifactorial disease associated with a violation of neurotransmitter processes and synaptic plasticity in the central nervous system, as well as dysregulation in the humoral immune system. Genome-wide association study of SNPs showed that in schizophrenia there is an association with the genes of the immune system and microRNAs [1]. Recently, catalytic antibodies or abzymes hydrolyzing DNA were found in the serum of patients with schizophrenia [2]. It is known that manipulating the levels of microRNA in the brain can alter the behavior [3]. Antibodies with nuclease activity may possibly destroy circulating regulatory nucleic acids and can play a role in behavioral disorders.Objectives: To investigate (a) DNA- and RNA-hydrolyzing activity of IgG antibodies isolated from the serum of patients with schizophrenia; (b) the cytotoxicity of isolated IgG on the human glioblastoma cell culture T98G.",

keywords = "IgG antibodies, nuclease activivty, abzymes",

author = "E. Ermakov and L. Smirnova and S. Ivanova and O. Zaharova and V. Buneva and G. Nevinsky",

note = "Copyright {\textcopyright} 2017 The Authors. Published by Elsevier B.V. All rights reserved.; 30th Congress of the European-College-of-Neuropsychopharmacology (ECNP) ; Conference date: 02-09-2017 Through 05-09-2017",

year = "2017",

month = jul,

day = "1",

doi = "10.1016/j.euroneuro.2017.04.002",

language = "English",

volume = "27",

pages = "633--646",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier Science Publishing Company, Inc.",

number = "7",

}

RIS

TY - JOUR

T1 - Neural response to catecholamine depletion in remitted bulimia nervosa

T2 - 30th Congress of the European-College-of-Neuropsychopharmacology (ECNP)

AU - Ermakov, E.

AU - Smirnova, L.

AU - Ivanova, S.

AU - Zaharova, O.

AU - Buneva, V.

AU - Nevinsky, G.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Introduction: Schizophrenia is known to be a multifactorial disease associated with a violation of neurotransmitter processes and synaptic plasticity in the central nervous system, as well as dysregulation in the humoral immune system. Genome-wide association study of SNPs showed that in schizophrenia there is an association with the genes of the immune system and microRNAs [1]. Recently, catalytic antibodies or abzymes hydrolyzing DNA were found in the serum of patients with schizophrenia [2]. It is known that manipulating the levels of microRNA in the brain can alter the behavior [3]. Antibodies with nuclease activity may possibly destroy circulating regulatory nucleic acids and can play a role in behavioral disorders.Objectives: To investigate (a) DNA- and RNA-hydrolyzing activity of IgG antibodies isolated from the serum of patients with schizophrenia; (b) the cytotoxicity of isolated IgG on the human glioblastoma cell culture T98G.

AB - Introduction: Schizophrenia is known to be a multifactorial disease associated with a violation of neurotransmitter processes and synaptic plasticity in the central nervous system, as well as dysregulation in the humoral immune system. Genome-wide association study of SNPs showed that in schizophrenia there is an association with the genes of the immune system and microRNAs [1]. Recently, catalytic antibodies or abzymes hydrolyzing DNA were found in the serum of patients with schizophrenia [2]. It is known that manipulating the levels of microRNA in the brain can alter the behavior [3]. Antibodies with nuclease activity may possibly destroy circulating regulatory nucleic acids and can play a role in behavioral disorders.Objectives: To investigate (a) DNA- and RNA-hydrolyzing activity of IgG antibodies isolated from the serum of patients with schizophrenia; (b) the cytotoxicity of isolated IgG on the human glioblastoma cell culture T98G.

KW - IgG antibodies

KW - nuclease activivty

KW - abzymes

UR - https://www.webofscience.com/wos/author/record/660484

U2 - 10.1016/j.euroneuro.2017.04.002

DO - 10.1016/j.euroneuro.2017.04.002

M3 - Article

C2 - 28502528

VL - 27

SP - 633

EP - 646

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 7

M1 - P.1.f.019

Y2 - 2 September 2017 through 5 September 2017

ER -

ID: 18734049